A1M was suggested to have potential in targeting heme toxicity in atherosclerosis by Jeney et al. in 2014 [134], proposing that it would battle atherosclerosis by targeting the heme toxicity and resulting oxidative stress. The gene discussed is AMBP; the disease is atherosclerosis.